Annual Long Term Debt
$4.91 M
-$30.39 M-86.10%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual long term debt is currently $4.91 million, with the most recent change of -$30.39 million (-86.10%) on 31 December 2023. During the last 3 years, it has fallen by -$35.40 million (-87.83%). EYPT annual long term debt is now -90.21% below its all-time high of $50.12 million, reached on 31 December 2019.EYPT Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$21.92 M
-$242.00 K-1.09%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly long term debt is currently $21.92 million, with the most recent change of -$242.00 thousand (-1.09%) on 30 September 2024. Over the past year, it has increased by +$16.74 million (+322.80%). EYPT quarterly long term debt is now -58.84% below its all-time high of $53.26 million, reached on 30 September 2020.EYPT Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -86.1% | +322.8% |
3 y3 years | -87.8% | -42.9% |
5 y5 years | -72.2% | -56.0% |
EYPT Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -87.8% | at low | -42.9% | +374.1% |
5 y | 5 years | -90.2% | at low | -58.8% | +374.1% |
alltime | all time | -90.2% | +3267.2% | -58.8% | +649.5% |
EyePoint Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $21.92 M(-1.1%) |
June 2024 | - | $22.16 M(+379.3%) |
Mar 2024 | - | $4.62 M(-5.7%) |
Dec 2023 | $4.91 M(-86.1%) | $4.91 M(-5.4%) |
Sept 2023 | - | $5.18 M(-4.9%) |
June 2023 | - | $5.46 M(-84.5%) |
Mar 2023 | - | $35.09 M(-0.6%) |
Dec 2022 | $35.29 M(-8.1%) | $35.29 M(-0.5%) |
Sept 2022 | - | $35.49 M(+4.3%) |
June 2022 | - | $34.01 M(+10.4%) |
Mar 2022 | - | $30.80 M(-19.8%) |
Dec 2021 | $38.42 M(-4.7%) | $38.42 M(+0.0%) |
Sept 2021 | - | $38.41 M(+0.4%) |
June 2021 | - | $38.25 M(-5.1%) |
Mar 2021 | - | $40.30 M(-0.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $40.31 M(-19.6%) | $40.31 M(-24.3%) |
Sept 2020 | - | $53.26 M(+0.7%) |
June 2020 | - | $52.88 M(+4.8%) |
Mar 2020 | - | $50.48 M(+0.7%) |
Dec 2019 | $50.12 M(+184.4%) | $50.12 M(+0.7%) |
Sept 2019 | - | $49.76 M(+0.7%) |
June 2019 | - | $49.40 M(+40.3%) |
Mar 2019 | - | $35.22 M(+101.7%) |
Dec 2018 | $17.62 M(+1.8%) | - |
Sept 2018 | - | $17.46 M(+0.9%) |
June 2018 | $17.31 M(+491.8%) | $17.31 M(+34.7%) |
Mar 2018 | - | $12.85 M(+197.4%) |
Dec 2006 | - | $4.32 M(+47.7%) |
June 2006 | $2.92 M(+1907.5%) | $2.92 M |
June 2001 | $145.70 K | - |
FAQ
- What is EyePoint Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual long term debt year-on-year change?
- What is EyePoint Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly long term debt year-on-year change?
What is EyePoint Pharmaceuticals annual long term debt?
The current annual long term debt of EYPT is $4.91 M
What is the all time high annual long term debt for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual long term debt is $50.12 M
What is EyePoint Pharmaceuticals annual long term debt year-on-year change?
Over the past year, EYPT annual long term debt has changed by -$30.39 M (-86.10%)
What is EyePoint Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of EYPT is $21.92 M
What is the all time high quarterly long term debt for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly long term debt is $53.26 M
What is EyePoint Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, EYPT quarterly long term debt has changed by +$16.74 M (+322.80%)